RxDoctor Payments Data

Elizabeth Branson

Acute Care · Santa Ana, CANPI 1023587516

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,008, more than ten times the $57 reported in 2021. Among acute care clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,919in general payments, 2019–2025

Across 161 payments — averaging $24.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$861
  • Lilly USA, LLC$698
  • Amgen$478
  • Pfizer$350
  • Johnson & Johnson$350
  • Mallinckrodt Hospital Products Inc.$238
  • plus $943 from 13 others

What the payments were for

  • Food & beverage$3,76996%
  • Education$1504%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,919 in reported general payments places this provider in the 90th percentile of 1,153 acute care providers in California.

See all acute care providers in California →

Medicare billing

Part B allowed, 2024
$142,626
Medicare patients
390
Services billed
1,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen858$15,757
OxycontinOxycodone Hcl35$10,727
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen400$9,471
Lidocaine46$7,055
MovantikNaloxegol Oxalate14$5,587
Oxycodone Hcl277$4,295
Gabapentin257$3,125
Fentanyl33$2,158
Pregabalin117$1,819
Morphine Sulfate ErMorphine Sulfate66$1,602
Tramadol Hcl194$1,247
Hydroxychloroquine Sulfate20$1,136
Naloxone Hcl20$1,024
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine47$785
Methocarbamol102$668

Paid to pharmacies, not to this prescriber.

Other acute care in Santa Ana

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →